Delivery Order SPE2DB22D3301-SPE2DB24FY4PP

Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $1.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,460.47 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4568275407 - FEBUXOSTAT 40 MG TABLET 30S. The delivery order has an ultimate completion date of May 19, 2025 and is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $1,518.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,497,445 units of Febuxostat 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of 4,563,472,907 units of febuxostat 40 mg tablets, with a potential value of $1,659.19. The delivery order has a completion date of January 30, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will deliver these pharmaceutical products from its Corporate Office location in Conshohocken,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the delivery of 40 milligram febuxostat tablets in 30-count packages, with a potential value of $1,423.80 and a completion date of February 2, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,236.52 firm-fixed-price contract is for the supply of febuxostat 40 mg tablets. There is no set-aside designation. Amerisourcebergen holds multiple Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for providing a wide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,296,599 units of Febuxostat 40 mg Tablets in 30-count packages. The contract has a ceiling value of $1,928.52 and is a Firm Fixed Price arrangement. It was awarded on July 30, 2024 with a performance period through July 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit organization and subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of febuxostat 40 mg tablets, a pharmaceutical product, to support military treatment programs and facilities. The firm fixed price contract has a ceiling value of $2,946.00 and a period of performance through April 1, 2024. In addition to this delivery order, AmerisourceBergen...
This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,672.36 contract is for the delivery of 30-count bottles of the medication febuxostat 40 mg tablets to support military treatment facilities and other federal healthcare programs. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,972.24 for the supply of 40 mg febuxostat tablets. The contract has an ultimate completion date of November 5, 2024 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FEBUXOSTAT 40 MG TABLET 30S. The contract has a firm fixed price of $1,494.03 and an ultimate completion date of May 20, 2025. The award was made on May 19, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY4PP
    Delivery Order

This is a $1,675.64 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the pharmaceutical product Febuxostat 40 mg tablets, supplied in 30-count packages.

Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to provide a wide range of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC, which has a potential value of up to $999,999,999.00 through December 31, 2025. No set-aside designation was used for this contract.

Generated 7/12/24, 10:40 AM